152 related articles for article (PubMed ID: 37653055)
1. Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome.
Villoslada-Blanco P; Pérez-Matute P; Recio-Fernández E; Íñiguez M; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Sci Rep; 2023 Aug; 13(1):14327. PubMed ID: 37653055
[TBL] [Abstract][Full Text] [Related]
2. Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; de Toro M; Oteo JA
Infect Dis Ther; 2022 Aug; 11(4):1541-1557. PubMed ID: 35618952
[TBL] [Abstract][Full Text] [Related]
3. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome.
Villoslada-Blanco P; Pérez-Matute P; Íñiguez M; Recio-Fernández E; Jansen D; De Coninck L; Close L; Blanco-Navarrete P; Metola L; Ibarra V; Alba J; Matthijnssens J; Oteo JA
Sci Rep; 2022 Dec; 12(1):21658. PubMed ID: 36522388
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
5. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
6. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
[TBL] [Abstract][Full Text] [Related]
7. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection.
Zhao AV; Crutchley RD; Guduru RC; Ton K; Lam T; Min AC
Retrovirology; 2022 Oct; 19(1):22. PubMed ID: 36273165
[TBL] [Abstract][Full Text] [Related]
8. The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy.
Fernandes SR; Leite AR; Lino R; Guimarães AR; Pineiro C; Serrão R; Freitas P
BMC Infect Dis; 2023 Aug; 23(1):553. PubMed ID: 37620821
[TBL] [Abstract][Full Text] [Related]
9. Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients.
Imahashi M; Ode H; Kobayashi A; Nemoto M; Matsuda M; Hashiba C; Hamano A; Nakata Y; Mori M; Seko K; Nakahata M; Kogure A; Tanaka Y; Sugiura W; Yokomaku Y; Iwatani Y
Sci Rep; 2021 Jan; 11(1):960. PubMed ID: 33441754
[TBL] [Abstract][Full Text] [Related]
10. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
Park TE; Mohamed A; Kalabalik J; Sharma R
Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
[TBL] [Abstract][Full Text] [Related]
11. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
[TBL] [Abstract][Full Text] [Related]
12. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy.
Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701
[TBL] [Abstract][Full Text] [Related]
13. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients.
Quiros-Roldan E; Castelli F; Bonito A; Vezzoli M; Calza S; Biasiotto G; Zanella I;
Cytokine; 2020 Feb; 126():154884. PubMed ID: 31670006
[TBL] [Abstract][Full Text] [Related]
14. Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine.
Ray S; Narayanan A; Giske CG; Neogi U; Sönnerborg A; Nowak P
ACS Infect Dis; 2021 May; 7(5):1104-1115. PubMed ID: 33346662
[TBL] [Abstract][Full Text] [Related]
15. Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy.
Gagliardini R; Gianotti N; Maggiolo F; Cozzi-Lepri A; Antinori A; Nozza S; Lapadula G; De Luca A; Mussini C; Gori A; Saracino A; Andreoni M; Monforte AD;
Int J Antimicrob Agents; 2021 Oct; 58(4):106406. PubMed ID: 34293454
[TBL] [Abstract][Full Text] [Related]
16. Low Frequency of Integrase Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients in Southeast China.
Lai J; Liu Y; Han X; Huang A; Lin J; Ao W; Ye H; Chen Y
Drug Des Devel Ther; 2021; 15():889-894. PubMed ID: 33679129
[TBL] [Abstract][Full Text] [Related]
17. Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens.
Baltazar-Díaz TA; Amador-Lara F; Andrade-Villanueva JF; González-Hernández LA; Cabrera-Silva RI; Sánchez-Reyes K; Álvarez-Zavala M; Valenzuela-Ramírez A; Del Toro-Arreola S; Bueno-Topete MR
Microorganisms; 2023 Apr; 11(4):. PubMed ID: 37110374
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
19. Variability in HIV-1 Integrase Gene and 3'-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy.
Acharya A; Tagny CT; Mbanya D; Fonsah JY; Nchindap E; Kenmogne L; Jihyun M; Njamnshi AK; Kanmogne GD
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106437
[No Abstract] [Full Text] [Related]
20. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]